EXACT SCIENCES CORP 4

SVP, General Counsel & Secretary James Herriott tendered or cashed out all of his Exact Sciences common stock, stock options, and RSUs on March 23, 2026 in connection with the Abbott merger at $105.00 per share.

On March 23, 2026, in connection with the closing of Abbott Laboratories’ acquisition of Exact Sciences Corporation at $105.00 per share in cash, SVP, General Counsel & Secretary James Herriott disposed of all of his equity interests in the issuer. This included the cash-out of 68,195 shares of common stock held directly and 1,762 shares held indirectly in a 401(k) plan, as well as the cancellation-for-cash of vested in-the-money stock options covering 793 shares at a $92.62 strike price and 2,861 shares at a $98.18 strike price, and the conversion or cash-out of 20,321 restricted stock units into merger consideration or assumed Abbott equity awards. Following these merger-related transactions, Herriott no longer held Exact Sciences equity, as the company became a wholly owned subsidiary of Abbott.

Filing Facts

CIK

1124140

Ticker

EXAS

Form

4

Source Type

sec

Accession

0001193125-26-118762

Alert Tier

6